The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study to evaluate the efficacy and safety of fruquintinib combined with tislelizumab and hepatic artery infusion chemotherapy (HAIC) for advanced colorectal cancer liver metastases: An updated analysis of survival.
 
Lu Wang
No Relationships to Disclose
 
Ti Zhang
No Relationships to Disclose
 
Qi Pan
No Relationships to Disclose
 
Yiming Zhao
No Relationships to Disclose
 
Weiping Zhu
No Relationships to Disclose
 
Xiaoyan Zhu
No Relationships to Disclose
 
Anrong Mao
No Relationships to Disclose
 
Jiamin Zhou
No Relationships to Disclose
 
Yun Feng
No Relationships to Disclose